Use of balloon-occluded retrograde transvenous obliteration with ethanolamine oleate for the treatment of hepatic encephalopathy in a cirrhotic patient with a large spontaneous splenorenal shunt

Journal of Gastroenterology

Volumn 33, Issue 3, 1998, Pages 424-427

  Numata, Kazushi ^a   Tanaka, Katsuaki ^a   Kiba, Takayoshi ^a   Saito, Satoru ^a   Shirato, Kazuhito ^a   Kitamura, Takehiko ^a   Sekihara, Hisahiko ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Hepatic encephalopathy; Spontaneous splenorenal shunt

Indexed keywords

MONOETHANOLAMINE OLEATE;

AGED; ARTICLE; BALLOON; CASE REPORT; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; PRIORITY JOURNAL; SCLEROTHERAPY; SPLENORENAL SHUNT; VEIN OCCLUSION;

AGED; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER CIRCULATION; LIVER CIRRHOSIS; OLEIC ACIDS; RENAL VEINS; SCLEROSING SOLUTIONS; SPLENIC VEIN; SURGICAL PROCEDURES, OPERATIVE;

EID: 0031777401     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350050107     Document Type: Article

References (11)

1. Takashi M, Igarashi M, Hino S, et al. Portal hemodynamics in chronic portal-systemic encephalopathy: Angiographic study in seven cases. J Hepatol 1985;1:467-476.
2. Hanna SS, Smith RB, Henderson JM, et al. Reversal of hepatic encephalopathy after occlusion of total portosystemic shunts. Am J Surg 1981;142:285-289.
3. Henderson JM. Treatment of post-shunt portal-systemic encephalopathy by embolization of the shunt. Hepatology 1989;9: 164-165.
4. Hashizume M, Kitano S, Yamaga H, et al. Haptoglobin to protect against renal damage from ethanolamine oleate sclerosant. Lancet 1988;11:340-341.
5. Uflacker R, Silva AO, Carneiro d'Albuquerque LA, et al. Chronic portosystemic encephalopathy: Embolization of portosystemic shunts. Radiology 1987;165:721-725.
6. Vavasseur D, Duvoux C, Cherqui D, et al. Chronic hepatic encephalopathy due to spontaneous splenorenal shunt: Successful treatment by transhepatic shunt embolization. Cardiovasc Intervent Radiol 1994;17:298-300.
7. Olson E, Yune HY, Klatte EC. Transrenal-vein reflux ethanol sclerosis of gastroesophageal varices. AJR 1984;143:627-628.
8. Koito K, Namieno T, Nagakawa T, et al. Balloon-occluded retrograde transvenous obliteration for gastric varices with gastrorenal or gastrocaval collaterals. AJR 1996;167:1317-1320.
9. Shioyama Y, Matsueda K, Horihata K, et al. Post-TIPS encephalopathy treated by occlusion balloon-assisted retrograde embolization of a coexisting spontaneous splenorenal shunt. Cardiovasc Intervent Radiol 1996;19:53-55.
10. Akahane T, Iwasaki T, Kobayashi N, et al. Changes in liver function parameters after occlusion of gastrorenal shunts with balloon-occluded retrograde transvenous obliteration. Am J Gastroenterol 1997;92:1026-1030.
11. 15N-ammonia in patient with cirrhosis: A three-compartmental analysis. Hepatology 1992;16:347-352.